Descripción

Biochemical pathway illustrating how a specific antioxidant compound modulates reactive oxygen species production and inflammatory cytokine signaling in the context of IBD pathogenesis.

Figure 10

Diagram

Source Paper

Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease.

Pharmaceuticals (Basel, Switzerland) (2023)

PMID: 37631065

DOI: 10.3390/ph16081150

Cite This Figure

![Figure 10: Biochemical pathway illustrating how a specific antioxidant compound modulates reactive oxygen species production and inflammatory cytokine signaling in the context of IBD pathogenesis.]()

> Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." *Pharmaceuticals (Basel, Switzerland)*, 2023. PMID: [37631065](https://pubmed.ncbi.nlm.nih.gov/37631065/)

<figure>
  <img src="" alt="Biochemical pathway illustrating how a specific antioxidant compound modulates reactive oxygen species production and inflammatory cytokine signaling in the context of IBD pathogenesis." />
  <figcaption>Figure 10. Biochemical pathway illustrating how a specific antioxidant compound modulates reactive oxygen species production and inflammatory cytokine signaling in the context of IBD pathogenesis.<br>  Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37631065/">37631065</a></figcaption>
</figure>

Evidencia relacionada

Curcumin para Ulcerative Colitis (UC)

Calificación B · 5 estudios

N-Acetyl Cysteine (NAC) para Inflammatory Bowel Disease (IBD) — General

Calificación D · 1 estudios